Share
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial
CANCER MEDICINE
Egle, A; Melchardt, T; Obrtlikova, P; Smolej, L; Kozak, T; Steurer, M; Andel, J; Burgstaller, S; Mikuskova, E; Gercheva, L; Nosslinger, T; Papapjik, T; Ladicka, M; Girschikofsky, M; Hrubisko, M; Jager, U; Voskova, D; Pecherstorfer, M; Kralikova, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochova, E; Palasthy, S; Stehlikova, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R, 2019: Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. CANCER MEDICINE 8(4), p. 1401 - 1405, doi: 10.1002/cam4.1980
CEITEC authors: